This page includes the latest FDA filings for Cidara Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | CDTX | DUNS 025485700 |
Device Company | Device | Date |
|---|---|---|
| Melinta Therapeutics, LLC, Mundipharma GmbH, Patheon Italia S.p.A. | Prescription Medication | 2025-12-24 |
| Melinta Therapeutics, LLC, Mundipharma GmbH, Patheon Italia S.p.A. | Prescription Medication | 2024-10-24 |
| Melinta Therapeutics, LLC, Mundipharma GmbH, Patheon Italia S.p.A. | Prescription Medication | 2023-06-13 |
| NCAGE Code | 7A5L2 | CIDARA THERAPEUTICS, INC. |
| CAGE Code | 7A5L2 | CIDARA THERAPEUTICS, INC. |
| S.A.M. Registration | 7A5L2 [25485700] | CIDARA THERAPEUTICS, INC. |
| DUNS | 025485700 | Cidara Therapeutics, Inc. |
| SEC | 0001610618 | Cidara Therapeutics, Inc. of DELAWARE |